[Pe-031] English Poster Session 031「Cerebellar ataxia and Myelopathy 2」

[Pe-031-1] Clinical biomarker discovery for potential disease-modifying drug of Spinocerebellar ataxia type 31

Hanako Aoki¹, Takeru Honda², Akiko Amano¹, Miwa Higashi¹, Tetsuya Nagata¹, Takanori Yokota¹, Kinya Ishikawa³ (1.Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, Japan, 2.Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University, Japan, 3.Department of Personalized Genomic Medicine for Health, Tokyo Medical and Dental University, Japan)